In a recent big-data, real-world study, researchers demonstrated that hospital mortality is not significantly different between septic patients treated with […]
Contrary to prior clinical trials, researchers have revealed that metastatic urothelial cancer patients with fibroblast growth factor receptor (FGFR) mutations […]
A recent phase II study used real-world evidence to assess responses to a combination treatment of atezolizumab and bevacizumab in […]
Although progress has been made in our understanding of the underlying pathophysiology of major depressive and bipolar disorders, there is […]
Regulatory agencies have recommended designing more representative trials of anti-diabetic drugs, but this first requires defining clinically relevant target populations […]
A recent study, published in Drug Safety, aimed to describe the adverse drug reactions reported in inflammatory bowel disease patients […]
Since demonstrating efficacy in clinical trials, the monoclonal antibody benralizumab has been licensed for the treatment of severe eosinophilic asthma. […]
A recent study aimed to assess the safety of intravitreal ranibizumab biosimilar molecule (Razumab) treatment for chorioretinal diseases under real-world […]
A recent study aimed to evaluate the outcomes of standard-of-care triple therapy versus two-drug treatment for HIV, following the observation […]
Clinical trials are used to determine the efficacy of a drug in patients. However, effective clinical trials that have a large […]
